US 11584737
Heterocyclic compound
granted A61PA61P35/00A61P43/00
Quick answer
US patent 11584737 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P35/00, A61P43/00